Uma Análise Comparativa De Parâmetros Do Doppler Transcraniano Adquiridos Durante A Colocação De Stent Carotídeo E Endarterectomia Carotídea Por Semieversão by Olveira G.P. et al.
O R I G I NAL  ART ICLE
197J Vasc Bras. 2016 July-Sept.; 15(3):197-204http://dx.doi.org/10.1590/1677-5449.003316
A comparative analysis of transcranial Doppler parameters 
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Abstract
Background: Carotid endarterectomy (CEA) and carotid artery stenting (CAS) have both been proposed for treatment 
of critical atherosclerotic stenosis located at the carotid bifurcation. Monitoring of hyperintense microembolic signals 
(MES) by transcranial Doppler ultrasound (TCD) is considered a method of quality control, both in CEA and in CAS. 
Objective: To analyze temporal distribution of MES throughout both semi-eversion CEA and CAS procedures 
and to evaluate changes in mean velocity of blood flow through the ipsilateral middle cerebral artery (MCA). 
Method: Thirty-three procedures (17 CEA and 16 CAS) were prospectively monitored using TCD and the data were 
related to three different stages of surgery (pre-cerebral protection, during cerebral protection and post-cerebral 
protection). Chi-square, Mann-Whitney, ANOVA and contrast tests were used for statistical analysis. Results: The MES 
were uniformly distributed in the CEA group, but not in the CAS group (p = 0.208). The number of MES was higher 
in the CAS group in all stages. The average flow in the MCA was similarly lower in both groups during the protection 
stage. Conclusion: CEA provoked a lower incidence of MES per procedure than CAS in all stages. The behavior of 
the averages of the mean of blood flow through the MCA was similar in both groups. 
Keywords: carotid stenosis; carotid endarterectomy; transcranial Doppler ultrasonography.
Resumo
Contexto: A endarterectomia carotídea (EC) e a angioplastia carotídea (AC) são propostas para o tratamento de 
estenoses críticas localizadas na bifurcação carotídea. O monitoramento dos sinais de microembolias (SMs) pela 
ultrassonografia Doppler transcraniana (UDT) é considerado um método de controle de qualidade para ambas as 
técnicas. Objetivos: Analisar a distribuição temporal dos SMs ao longo de diferentes estágios da EC por semieversão 
e da AC, e avaliar o significado das mudanças nas médias das velocidades médias do fluxo na artéria cerebral média 
ipsilateral (ACM). Método: Trinta e três procedimentos (17 ECs e 16 ACs) foram monitorados com UDT, e os dados 
foram coletados prospectivamente para diferenciar os diferentes estágios cirúrgicos (pré, durante e pós-proteção 
cerebral). Para análise estatística foram usados os testes qui-quadrado, Mann-Whitney, análise de variância (ANOVA) 
e contraste. Resultados: Em ambos os grupos, os SMs foram distribuídos uniformemente (p = 0,208). Em todos os 
tempos, o número de SMs foi superior no grupo AC. A média das velocidades médias do fluxo na ACM foi menor 
durante o tempo de proteção em ambos os grupos. Conclusão: A EC teve uma menor incidência de SMs que a AC 
em todos os estágios. A média das velocidades médias na ACM teve comportamento similar em ambos os grupos. 
Palavras-chave: estenose das carótidas; endarterectomia das carótidas; ultrassonografia Doppler transcraniana.
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INTRODUCTION
Carotid endarterectomy (CEA) and carotid 
artery stenting (CAS) have both been proposed for 
treatment of critical atherosclerotic stenosis located 
at the carotid bifurcation. It has been scientifically 
accepted that CAS is increasingly an important 
alternative to CEA.1-3
Transcranial Doppler ultrasound (TCD) is a 
non-invasive technique that has been used during carotid 
revascularization with the objective of monitoring 
hemodynamic changes as well as for identifying 
hyperintense microembolic signals (MES) resulting 
from embolic materials.4
Some studies have reported that microemboli can 
predict cerebrovascular symptoms,5-7 but this has not 
been confirmed by others.8,9 There is evidence that 
these microemboli can also contribute to dementia.10,11 
Monitoring of MES by TCD is considered a method 
for quality control, both in CEA and in CAS.12,13
This study aims to analyze the temporal distribution 
of MES throughout three different stages of both CEA 
(semi-eversion technique) and CAS and to evaluate 
changes in mean velocity of blood flow in the middle 
cerebral artery (MCA).
METHODS
Institutional review board approval was obtained 
to prospectively analyze patients who would undergo 
elective carotid revascularization with TCD monitoring. 
The TCD endpoints were the number of ipsilateral 
MES generated during the procedure, its temporal 
distribution, and also the variation of the averages of 
mean velocity in the ipsilateral MCA. The procedures 
were divided into three stages: pre-cerebral protection 
(until the internal carotid artery [ICA] is clamped or 
a distal filter deployed), during cerebral protection 
(until antegrade flow in the ICA is re-established or 
the filter removed) and post-cerebral protection (after 
antegrade blood flow in the ICA is re-established or 
the filter removed). Cerebral protection time was 
measured in seconds and corresponded to the duration 
of the second stage. Another variable analyzed was 
the duration of ischemia, which was classified as the 
period of time during which the average velocity of 
blood flow within the MCA fell below 30 percent of 
the pre-procedural velocity.
Patients
From January 2010 to January 2012, a total 
of 60 carotid revascularization procedures were 
performed at the Universidade Estadual de Campinas 
(UNICAMP) University Hospital. The study was 
approved by the UNICAMP ethics committee and all 
patients signed an informed consent form prior to all 
procedures. Therefore, this study was performed in 
accordance with the 1964 Declaration of Helsinki. 
Treatment for symptomatic disease was offered for 
stenosis greater than 70%, according to the North 
American Symptomatic Carotid Endarterectomy 
Trial (NASCET) criterion,14 while for asymptomatic 
patients, the cutoff was 80%, in accordance with 
Asymptomatic Carotid Atherosclerosis Study (ACAS) 
recommendations.15 The severity of carotid stenosis 
was determined by Duplex ultrasound (DUS) and 
confirmed by angiography or angiotomography.
Patients were excluded because of the following: 
absence of a bone window for TCD monitoring 
(12 patients); carotid restenosis (1 patient); combined 
procedures (3 patients); presence of concurrent 
stenosis in the target artery (5 patients); need for 
urgent intervention (3 patients); and severe renal 
insufficiency (Cr > 2.0) (3 patients). Thirty-three 
carotid revascularization procedures (17 CEA and 
16 CAS) were conducted with TCD monitoring and 
the data were prospectively entered into a database.
Tables 1 and 2 summarize baseline patient 
characteristics broken down by method of carotid 
revascularization. Overall, 87.8% of the patients were 
male and their mean age was 71.2 years. Hypertension 
and smoking history (more than 20 pack-years, 
quit ≥ 1 year previously) were prevalent in both 
treatment groups and both treatment groups included 
symptomatic and asymptomatic patients.
Carotid revascularization procedures
Criteria for selection of type of procedure (CEA 
or CAS) were in accordance with American Heart 
Association and American Stroke Association guidelines.1 
Carotid artery stenting was only considered for patients 
with: open heart surgery < 6 weeks; myocardial 
infarction < 4 weeks; angina CCS (Canadian Cardiac 
Score) class III/IV; chronic heart failure class III/IV; 
ejection fraction < 30%; abnormal cardiac stress test; 
chronic oxygen therapy; resting pO2 < 60%; forced 
expiratory volume in 1 second < 50% predicted; 
previous ipsilateral CEA; cervical radiation treatment; 
high cervical lesion (at least C2); lesion below the 
clavicle; contralateral laryngeal palsy.
All physicians were trained in vascular and 
endovascular surgery. The protocols for CEA and 
CAS were standardized for general anesthesia or 
local anesthesia (according to the anesthesiologist’s 
preferences) and intraoperative TCD monitoring.
199J Vasc Bras. 2016 July-Sept.; 15(3):197-204
Germano da Paz Olveira, Ana Terezinha Guillaumon et al.
Carotid endarterectomy
Patients were treated with 200 mg of aspirin during 
the perioperative period. Plaques were endarterectomized 
using a standard semi-eversion technique performed 
by a vascular surgeon. This technique involves a 
longitudinal arteriotomy limited to the carotid bulb, 
removal of the plaque using eversion, and closure 
of the arteriotomy.16 The semi-eversion technique 
permits a smaller arteriotomy and, consequently, a 
shorter clamping time. A bovine pericardial patch 
was used in cases in which arteries had diameters 
smaller than 7 mm, which occurred in one patient, 
with the intention of reducing the total duration of the 
procedure and the rate of infections. The criteria for 
using a shunt in this study was a 70 percent reduction 
in baseline mean flow velocity in the MCA after 
internal carotid clamping, but none of the patients 
in this cohort required shunting. After intravenous 
administration of heparin (80-100 IU/kg), the internal, 
external, and common carotid arteries were occluded, 
in that order. Heparin was reversed selectively by the 
anesthesiologist using protamine.
It is worth mentioning the method of unclamping 
used in the study. The internal and external carotid 
arteries were unclamped before unclamping of the 
common carotid artery, to achieve a backward flush 
from the ICA. Next, the ICA was clamped and only 
then was the common carotid artery unclamped, 
allowing blood to flow into the external carotid artery. 
Finally, the ICA was unclamped.
Carotid artery stenting17
Patients were treated with 200 mg of aspirin and 
75 mg of clopidogrel during the perioperative period. 
Patients were heparinized with 80-100 UI/kg, an arch 
angiogram was performed and the target carotid was 
selectively cannulated, in all cases by femoral puncture 
and using a coaxial system comprising a long catheter 
(5 French) with Simons 2 or Multipurpose tip, and a 
long sheath (6 French) with a straight tip. Distal filters 
used were SpiderFx (EV3 Endovascular Inc, Plymouth, 
Minn). Seven-mm or 8-mm self-expanding stents were 
deployed and postdilated to 5 or 6 mm. Stents used 
included the Protégé RX (EV3 Endovascular Inc), 
an open-cell stent variety. Atropine was administered 
Table 1. Clinical and epidemiologic data (categorical variables).
Variables CEA (n = 17) CAS (n = 16) Total (n = 33) p-value
Male 15 (88.2%) 14 (87.5%) 29 (87.8%) 1.000*
Diabetes 6 (35.3%) 9 (56.2%) 15 (45.4%) 0.226†
Smoking history < 1 year 3 (17.6%) 3 (18.7) 6 (18.2%) 1.000*
Hypertension 15 (88.2%) 12 (75%) 27 (81.8%) 0.398*
Dyslipidemia 7 (41.2%) 10 (62.5%) 17 (51.5%) 0.220†
Renal insufficiency 0 (0%) 1 (6.2%) 1 (3.0%) -
Smoking history > 1 year 11 (64.7%) 11 (68.7%) 22 (66.7%) 0.805†
CAD 5 (29.4%) 11 (68.7%) 16 (48.5%) 0.023†
Right-sided lesion 10 (58.8%) 6 (37.5%) 16 (48.5%) 0.220†
Total contralateral obstruction 1 (5.9%) 4 (25%) 5 (15.1%) 0.192*
70-99% contralateral obstruction 1 (5.9%) 2 (12.5%) 3 (9.1%) 0.192*
Symptomatic 7 (41.2%) 6 (37.5%) 13 (39.4%) 0.829†
General anesthesia 16 (94.1%) 8 (50%) 24 (72.7%) 0.006*
CAD: coronary artery disease; CAS: carotid artery stenting; CEA: carotid endarterectomy. *Fisher test;  †chi-square test.
Table 2. Clinical and epidemiologic data (numerical variables).
Groups Variables
CEA (n = 17) CAS (n = 16)
p-value*
Mean SD Min Med Max Mean SD Min Med Max
Age (years) 71.5 5.6 63 69 81 70.9 7.1 54 72.5 78 0.772
Protection time (s) 1016.5 343.7 540 1020 2160 881 309.2 393 799.5 1360 0.357
Number of MES 89.8 171.4 5 46 745 597.5 343.3 172 610.5 1640 <0.0001
MBP variation (mmHg) 22.6 8 10 23 35 21.1 10.7 5 21 40 0.563
Duration of ischemia (s) 0 0 0 0 0 33.8 83.4 0 0 312 -
CAS: carotid artery stenting; CEA: carotid endarterectomy; MBP: mean systemic arterial blood pressure; MES: microembolic signals; SD: standard deviation. 
Mann-Whitney test.
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selectively. Residual stenosis of 20% was considered 
an acceptable result. Contrast was injected after stent 
deployment to enable control imaging and there were 
no findings suggestive of vasospasm.
Transcranial Doppler ultrasound18
Before the procedure, patients were examined by 
mapping out the blood flow of the MCA to confirm 
the acoustic window, using a TCD Sonara-USA, a 
2-channel device with a 2 MHz transducer. New 
measures were taken during the procedures. The TCD 
was fitted over the temporal bone above the zygomatic 
arch on the side of the target carotid. Microembolic 
signals were identified automatically and recorded 
on a hard drive, and were collected across a wide 
insonation gate set at 45 to 55 mm, with a sample 
size of 5 mm. Each stage of the procedure was timed. 
The number of MES and measures of the average 
velocity of blood flow in the MCA were obtained by 
analyzing these data after the procedure, excluding 
signals that were related to interference produced by 
the electric scalpel or contrast injection. These values 
were automatically recorded by the machine, which 
has been validated in previous reports.17,19
Statistical analysis
Descriptive analysis consisted of tables of frequencies 
for categorical variables and measures of position and 
dispersion for numerical variables. The chi-squared test 
or (when necessary) Fisher’s exact test were employed 
to compare proportions and the Mann-Whitney test 
was used to compare numerical measures. Analysis 
of variance (ANOVA) for repeated measures with 
rank transformation was conducted, followed by 
contrast tests, in order to compare groups, procedural 
stages, and the interaction between them. The level of 
statistical significance used was α = 5%. All statistical 
calculations were performed using SAS for Windows 
(Statistical Analysis System, version 9.2.; SAS Institute 
Inc, 2002-2008, Cary, NC, USA).
RESULTS
The majority of clinical epidemiological data did 
not differ statistically between groups, but the groups 
were different in terms of coronary artery disease 
(CAD) and type of anesthesia (Tables 1 and 2). 
One of the 33 patients suffered a stroke, followed 
by death, 25 days after the procedure. This patient 
had undergone CAS with local anesthesia. All of the 
other patients were successfully treated with carotid 
revascularization with no complications (such as 
stroke, myocardial infarction, or death). Doppler US 
of the neck revealed no stenosis at 30 days.
Analysis of the intraoperative TCD data shown in 
Table 2 reveals important differences in duration of 
ischemia. However although this could be relevant 
from a clinical point of view, in terms of statistics 
this difference cannot be shown because there was no 
variation in the CEA group. No conceptual ischemia 
(< 30% of baseline) occurred during the procedure 
to treat the patient who later died .
There was a statistically significant difference 
between the groups (p < 0.0001) for the number 
of MES detected (Table 2). There was a mean of 
89.8 (± 171.4) microembolic signals per procedure in 
the CEA group, while the mean number in the CAS 
group was 597.5 (± 343.3). A total of 661 microembolic 
signals were detected during the procedure to treat 
the patient who eventually died. This patient was in 
the CAS group, in which the maximum number of 
signals was 1640.
The distribution of MES across the three stages of 
the procedures can be observed in Table 3 and is also 
illustrated in Figure 1. In the CEA group, the MES were 
uniformly distributed (p = 0.208). However, in the CAS 
group, notable differences (p < 0.0001) were detected 
between the pre-protection and post-protection stages 
and also between the during protection stage and the 
post-protection stage. No statistical differences were 
found between the first and second stages. In effect, 
the mean number of MES was higher in the CAS 
group in all three stages.
Table 3. Ipsilateral MES broken down by protection stages and carotid revascularization procedures.
Groups
Protection stage
CEA (n = 17) CAS (n = 16)
p-value*
Mean SD Min Med Max Mean SD Min Med Max
Pre-protection 51.6 146 0 13 615 291.8 275.1 16 210 1125 <0.0001
During protection 16.6 23 0 8 74 230.1 125.1 99 167,5 494 <0.0001
Post-protection 22.2 18.9 2 15 60 75.6 80.8 0 53 312 0.009
Total† 89.8 171.4 5 46 745 597.5 343.3 172 610.5 1640 <0.0001
CAS: carotid artery stenting; CEA: carotid endarterectomy; SD: standard deviation. *Comparison between groups using the ANOVA test; †Comparison between the 
protection stages using the ANOVA test: for the CEA group, there was no statistical difference between the stages; for the CAS group, p < 0.0001 for pre-protection 
versus post-protection, and for during protection versus post-protection, but no statistical difference between pre-protection and during protection.
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Another important group of variables analyzed is 
the averages for mean blood flow velocities in the 
ipsilateral MCA (Table 4 and Figure 2). It is important 
to note that the variations in the average velocities 
were similar in both groups (p = 0.152). Furthermore, 
in both groups, the mean blood flow velocity within 
the MCA fell after the transition from pre-protection 
to during protection, and rose once again during 
post-protection, attaining values that were higher 
than both preceding stages (p <0.0001).
Figure 1. Average values with standard deviation of the number of MES in each protection stage.
Table 4. Analysis of the averages of mean velocities of blood flow (cm/s) in the ipsilateral MCA, broken down by protection stages 
and carotid revascularization procedures.
Groups
Protection stage
CEA (n = 17) CAS (n = 16)
p-value*
Mean SD Min Med Max Mean SD Min Med Max
Pre-protection 37.9 8.7 21 36 55 48.4 12.5 31 45.5 78 0.152
During protection 35.7 14.9 11 34 69 39.1 12.2 24.1 38.2 72.5 0.152
Post-protection 48.3 15.3 27 45 85 50 27 0.8 48.5 110 0.152
p-value† <0.0001 <0.0001 -
CAS: carotid artery stenting; CEA: carotid endarterectomy. *Comparison between groups using the ANOVA test; †Comparison between protection stages using 
the ANOVA test.
Figure 2. Average values with standard deviation of the mean velocities in the ipsilateral MCA in each protection stage.
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DISCUSSION
The correlation between microembolization detected 
by TCD during CEA and cerebral ischemia was 
demonstrated in 1994.20 According to one important 
study,19 both gaseous and solid emboli can cause 
cerebral injuries during carotid revascularization. 
In the present study, this distinction was not made. 
Another relevant feature of this study relates to counting 
microemboli and the manner in which noise related 
to contrast injection and electrical interference from 
the electric scalpel was excluded. A previous study 
has suggested it is necessary to discard these data to 
avoid methodological errors, but the study authors 
did not provide details on how to do this.9 These 
recommendations were followed in the present study. 
However, it was noted that the number of MES rose 
after contrast injection and during use of the electric 
scalpel, but did not sink back to baseline levels after 
these phases were over. These extra signals were 
not discarded in the present study and it is possible 
that these peculiarities are linked to the observation 
of a higher number of MES, in comparison to other 
studies.4,9,17,19
Given the sample size studied, it was not possible 
to relate microemboli to morbid events. However, 
it was demonstrated that MES were significantly 
more prevalent in patients treated with CAS, and 
this phenomenon was observed in all three stages 
of the procedure. Some studies have reported the 
same finding.4,9,17,19 The present study also found 
that the temporal distribution of microemboli was 
different in each group. In the CEA group, there was 
no statistical difference in the distribution of MES 
across the three stages, but in the CAS group, MES 
were most prevalent in the pre-protection and during 
protection stages.
To a certain extent, the results for CEA, contradict 
the findings of other authors21 who demonstrated 
differences in the temporal distribution of microemboli. 
They state that distal control of the internal carotid 
and installation of the shunt, both crucial moments 
during CEA, would result in more embolization.21 
However, there are two aspects that differentiate the 
present study from that one: 1) in the present study, 
the technique used for endarterectomy (semi-eversion) 
results in less distal exposure and manipulation of 
the internal carotid artery; 2) it was not necessary to 
use a shunt in any of the cases in the present study.
On the other hand, MES noted during clamping could 
be explained by possible contralateral microemboli 
and intracranial atheroemboli. Furthermore, MES 
were undoubtedly more common when the internal 
and external carotid arteries were unclamped, 
while the common carotid artery was still clamped 
(see Methods section).
The data observed for the CAS group demonstrated 
a tendency to greater occurrence of MES in the 
pre-protection stage, although there was no statistical 
difference in relation to the second stage. It was 
clear that it was only once the stent was correctly 
positioned and arterial manipulation ceased, in the 
post-protection stage, that a significant drop in the 
number of MES occurred. Furthermore, it could be 
argued that the initial manipulation of the aortic arch 
and manipulation of the carotid lesion without any 
protection generate microemboli and that even once 
the distal filter has been installed protection is still 
incomplete since debris can escape through the filter 
or around the filter, which has been documented.22
Given that many neurological events can occur 
after removal of the brain-protection device, it can be 
assumed that a large number of carotid lesions treated 
with CAS continue to release embolic material after 
carotid intervention.23,24 These authors suggest that 
using closed-cell stents results in a significant decrease 
in post-procedural neurological events. However, two 
more recent studies25,26 found no difference between 
groups treated using closed and open-cell stents. 
The results of these more recent studies should avert 
any criticism of the exclusive use of open-cell stents 
in the present study.
The increase in velocity of blood flow through 
the MCA after carotid revascularization has been 
investigated by several authors.27,28 As was to be 
expected, the average blood flow velocity in the 
ipsilateral middle cerebral artery increased after all 
procedures.
Another important point is the reduction in 
average velocities during protection, observed in both 
groups, notwithstanding that this did not necessarily 
mean that the patient reached conceptual ischemia 
(< 30% of baseline). Other authors have observed 
several cases of this reduction in average blood 
flow velocity during CEA procedures, but in that 
study only 16 out of 49 patients exhibited a drop in 
blood velocity resulting in ischemia.29 It is relevant 
to note that while the CEA group in the present 
study did not have any cases of conceptual ischemia 
(< 30% of baseline), there was one case in the CAS 
group in which ischemia occurred for 312 seconds. 
However, there is a difference between this study and 
the one cited above,29 in that it defined ischemia as 
the period of time during which blood flow fell below 
50% of the baseline blood flow, rather than 30%.
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In the present study there was a similarity between 
the groups in terms of how the averages of the mean 
velocities decreased in the second stage, which 
was expected for CEA, but went against the initial 
hypothesis that CAS with a distal filter would not 
disrupt anterograde blood flow. In addition to saturation 
of the filter, there are other factors that contributed to 
this reduction, such as placement of the stent within 
the residual lumen of the internal carotid and the later 
balloon expansion of the stent.
In conclusion, in the light of TCD findings, CEA 
(semi-eversion technique) resulted in a lower incidence 
of MES than CAS with a distal filter in all protection 
stages, with a uniform temporal distribution in the 
CEA group and greater occurrence of MES in the 
first two stages in the CAS group. The averages of 
the mean velocity of flow within the MCA behaved 
similarly in both groups: the averages of the mean 
velocities tended to fall from the first to the second 
stage, and then rise from the second to the third, 
reaching levels higher than those in the first stage.
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